Venture: Driving Growth

B-BIC Helps Investigators Build Business Skills

September 3, 2019

If you’re a Partners investigator who is interested in moving a discovery from your lab into the clinic, the programs offered by the Boston Biomedical Innovation Center (B-BIC) can help to prepare you for the professional and personal challenges that lie ahead. One of three NIH Centers for Accelerated Innovation (NCAIs), B-BIC is supported by…

Read More

Case Closed: Taking the Mystery Out of Start-Ups and Venture Capital Funding

April 30, 2018

Medical innovation often gets its start incubated inside a start-up company that receives needed financing from venture capitalists. The fifth Symposium Series session, held at Simches on February 28th, focused on how to leverage venture capital financing to translate and commercialize medical research inside of a start-up company. The event featured two sessions: a fireside…

Read More

$171M Gives PIF Added Speed and Scale

January 8, 2018

After a decade of success in funding new technologies through the Partners Innovation Fund (PIF), the Partners HealthCare System (PHS) has closed on $171.1 million in new capital for Partners Innovation Fund II. The funds will be used to support the development of new technologies that emerge from the research laboratories in the Partners HealthCare…

Read More

Partners HealthCare raises $171 million to invest in early-stage life science companies

November 17, 2017

I am excited to announce that Partners HealthCare System has closed on $171.1 million in capital to invest in early-stage life sciences companies, which are a critical segment of the state’s innovation economy. The funds raised include $66.1 million in outside capital for Partners Innovation Fund II and a $105 million commitment from Partners institutions…

Read More

Partners HealthCare raises $171 million to invest in early-stage life science companies

November 8, 2017

Partners HealthCare System announced today the closing of $171.1 million in capital to invest in early-stage life sciences companies, which are a critical segment of the state’s innovation economy. The funds raised include $66.1 million in outside capital for Partners Innovation Fund II and a $105 million commitment from Partners institutions to Partners Innovation Fund. …

Read More

Editas-MGH CRISPR Collaboration Expands the Toolbox

October 13, 2016

Partners HealthCare spinoff Editas rose to fame in 2014 when it was named to Fierce Biotech’s prestigious Fierce 15, an annual compilation of leading biotech upstarts. Since then, Editas’ technology has received worldwide acclaim as a user-friendly way with the potential to edit virtually any site in the human genome. The technique relies on material…

Read More

Partners Innovation Fund Grows to $100 Million

January 12, 2016

Nine years ago, a grand Partners HealthCare experiment was launched. Not on a laboratory bench or in an exam room but on an organization-wide scale. With $35 million at stake, the concept was to run a venture model from within Partners with ready capital and experienced internal venture investors who could steward the creation of…

Read More

Love of Teaching Yields Potent New Drug Candidate, Major Acquisition

September 1, 2015

Partners HealthCare spin-off, Adheron, is acquired by Roche for $580 million. When pharmaceutical giant Roche announced plans to acquire Partners spinoff Adheron Therapeutics in September, immunologist Michael Brenner, MD, couldn't help but recall the unlikely events that inspired the spinoff. The original spark that ignited Adheron's promising therapy for inflammatory and autoimmune diseases, and fibrosis…

Read More

GeneInsight – Timely, Actionable, Impactful

June 1, 2015

Partners HealthCare Spin-off, GeneInsight, makes personalized medicine a reality for patients throughout the United States. Dazzling discoveries in genomics and genetics are ushering in new possibilities for precision medicine. But simmering beneath the surface of this excitement is a layer of uncertainty: As researchers expand the list of disease-associated genes, laboratories are debating the best…

Read More

Partners Innovation Fund

June 1, 2015

Creating, financing and growing companies. A patient’s clinical problem profile, assembled in seconds from voluminous electronic medical records. A laser-activated lotion that ameliorates severe acne without the need for a systemic drug. An antibody that could one day prevent joint destruction in patients with rheumatoid arthritis. These are a few of the many innovative ideas…

Read More

Spinoff Profile: Raze Therapeutics

April 1, 2015

A look at the promising oncology therapeutics under exploration by Partners HealthCare spin-off, Raze Therapeutics. A new approach to treating certain cancers may lie in an often-overlooked corner of amino acid metabolism, according to the science behind a new Partners spinoff. Promising oncology therapeutics under exploration by Raze Therapeutics aim to dismantle a metabolic pathway…

Read More

Novel Treatments for Kidney Diseases and Ovarian Cancer Therapy

December 1, 2014

A look into two of Innovation's Discovery Grant Profiles. Novel Treatments for Kidney Diseases Joseph Bonventre, MD, PhD BWH, RENAL Acute Kidney Injury is characterized by a rapid decline in kidney function and can be triggered by a number of insults. While AKI may resolve on its own or with care, the sequelae can include…

Read More

Annovation BioPharma

December 1, 2014

Partners HealthCare spinoff, Annovation BioPharma's next-generation intravenous anesthetic, ABP700, garnered promising clinical results and is expected to be acquired by The Medicines Company in early 2015. The Massachusetts General Hospital has been celebrated worldwide for nearly 200 years of anesthetic innovation – the iconic image of the Ether Dome surgery is hallowed throughout the medical…

Read More

Fierce 15: Two Partners Spinoffs Awarded Honors

December 1, 2014

Earlier this fall, Partners HealthCare spinoffs Editas Medicine and Spero received global recognition. Earlier this fall, Partners HealthCare spinoffs Editas Medicine and Spero received global recognition when they were named to the prestigious Fierce Biotech's Fierce 15, an annual compilation of leading biotech upstarts. Researchers around the globe are pursuing various strategies for correcting defective…

Read More

CoStim's Novel Biologics Target Immune Checkpoint Inhibitors

December 1, 2013

Partners HealthCare spin-off, CoStim Pharmaceuticals, positioned to be a leader in the immune checkpoint regulation market. With excitement growing around immune checkpoint regulation as a major advance in treating cancer, the emergence of Partners HealthCare spin-off CoStim Pharmaceuticals could not be better timed. Industry experts expect the immune checkpoint therapy market will continue to grow…

Read More

Daktari Device a Global Health Game Changer

December 1, 2013

A look into the future of Daktari Diagnostics and their handheld CD4 cell counter. Daktari Diagnostics' slogan says it all: “Today There is No Place Out of Reach.” When it officially launches in the first quarter of 2014, Daktari's handheld CD4 cell counter will enable millions of people in developing nations living with HIV to…

Read More